BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3679901)

  • 1. Relevance of soluble cytotoxic factors generated by mycoplasma-contaminated targets to natural killer cell-mediated killing.
    Hommel-Berrey GA; Brahmi Z
    Hum Immunol; 1987 Sep; 20(1):33-46. PubMed ID: 3679901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
    Wayner EA; Brooks CG
    J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI; Brahmi Z
    Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
    Bonavida B; Wright SC
    J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
    Wright SC; Wilbur SM; Bonavida B
    Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
    Xiao J; Brahmi Z
    Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B; Katz J; Hoshino T
    Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
    Steinhauer EH; Doyle AT; Reed J; Kadish AS
    J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Agostini C; Chisesi T; Vespignani M; Pizzolo G; Pandolfi F; Ensoli F; Semenzato G
    Leuk Res; 1989; 13(4):315-22. PubMed ID: 2497276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.